
Integra LifeSciences Holdings Corporation IART
€ 15.51
5.67%
Quartalsbericht 2026-Q1
hinzugefügt 05.05.2026
Integra LifeSciences Holdings Corporation Operativer Cashflow 2011-2026 | IART
Operativer Cashflow Jährlich Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129 M | 140 M | 264 M | 312 M | 204 M | 231 M | 200 M | 115 M | 116 M | 105 M | 83.6 M | 53.3 M | 59.1 M | 104 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 312 M | 53.3 M | 151 M |
Operativer Cashflow Vierteljährlich Integra LifeSciences Holdings Corporation
| 2026-Q1 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9.8 M | - | -11.3 M | - | - | 15.8 M | - | - | 26.2 M | - | 179 M | - | 44.3 M | - | 243 M | - | 69.1 M | - | 124 M | 53.9 M | 20.8 M | - | 142 M | 78 M | 29.5 M | - | 157 M | 77.7 M | 41.5 M | - | 103 M | 57.8 M | 28.9 M | - | 110 M | 63.1 M | 25 M | - | 79.2 M | 59.6 M | 31.6 M | - | 58.7 M | 27.6 M | 11.3 M | - | 41.6 M | 10.8 M | 7.85 M | - | 62.5 M | 34.6 M | 32.3 M | - | 69.6 M | 45.8 M | 21.3 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 243 M | -11.3 M | 60.1 M |
Operativer Cashflow anderer Aktien in der Medizinische Geräte
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Cutera
CUTR
|
-138 M | - | -10.19 % | $ 1.99 M | ||
|
EDAP TMS S.A.
EDAP
|
-13.6 M | - | - | $ 162 M | ||
|
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.02 M | - | - | $ 3.31 B | ||
|
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | ||
|
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | ||
|
ClearPoint Neuro
CLPT
|
-23.9 M | $ 13.59 | 1.57 % | $ 385 M | ||
|
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | ||
|
Alphatec Holdings
ATEC
|
45.2 M | $ 8.26 | 4.42 % | $ 1.24 B | ||
|
Aziyo Biologics
AZYO
|
-44.8 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
-10.4 M | - | 37.08 % | $ 85.7 M | ||
|
BIOLASE
BIOL
|
-14.1 M | - | -13.19 % | $ 166 K | ||
|
IRIDEX Corporation
IRIX
|
-2.12 M | $ 1.12 | 0.9 % | $ 19 M | ||
|
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | ||
|
Helius Medical Technologies
HSDT
|
-16.5 M | $ 1.48 | 7.25 % | $ 32.6 M | ||
|
LivaNova PLC
LIVN
|
254 M | $ 77.17 | 3.17 % | $ 4.21 B | ||
|
Cytosorbents Corporation
CTSO
|
-12.4 M | $ 0.42 | 2.0 % | $ 26.1 M | ||
|
Pulmonx Corporation
LUNG
|
-32.4 M | $ 1.53 | 2.68 % | $ 62.2 M | ||
|
OrthoPediatrics Corp.
KIDS
|
-4.85 M | $ 18.49 | 1.43 % | $ 434 M | ||
|
Delcath Systems
DCTH
|
22.5 M | $ 11.69 | 6.86 % | $ 419 M | ||
|
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M | ||
|
Orthofix Medical
OFIX
|
33.3 M | $ 9.87 | 1.86 % | $ 391 M | ||
|
LENSAR
LNSR
|
-14.8 M | $ 5.69 | 1.61 % | $ 68 M | ||
|
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
11.4 M | $ 36.29 | -2.13 % | $ 307 M | ||
|
MiMedx Group
MDXG
|
74 M | $ 3.71 | 0.27 % | $ 548 M | ||
|
Butterfly Network
BFLY
|
-12.7 M | $ 5.12 | 7.11 % | $ 1.27 B | ||
|
Second Sight Medical Products
EYES
|
-24.3 M | - | -0.97 % | $ 54.4 M | ||
|
Myomo
MYO
|
-14.5 M | $ 1.31 | 2.34 % | $ 54.8 M | ||
|
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | ||
|
Globus Medical
GMED
|
753 M | $ 82.52 | 5.39 % | $ 11.2 B | ||
|
Insulet Corporation
PODD
|
569 M | $ 159.61 | 5.35 % | $ 11.2 B | ||
|
Profound Medical Corp.
PROF
|
-38.2 M | $ 6.82 | 3.81 % | $ 206 M | ||
|
CONMED Corporation
CNMD
|
171 M | $ 36.9 | 6.99 % | $ 1.15 B | ||
|
Inspire Medical Systems
INSP
|
117 M | $ 42.21 | 0.64 % | $ 1.24 B | ||
|
Integer Holdings Corporation
ITGR
|
196 M | $ 94.1 | 2.41 % | $ 3.27 B | ||
|
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
1.6 B | $ 87.54 | 1.97 % | $ 51.2 B | ||
|
Sintx Technologies
SINT
|
-8.57 M | $ 2.15 | 3.86 % | $ 5.96 M |